Jun 16, 2020
Actinium Pharmaceuticals, Inc. Announces Proposed Public Offering
May 29, 2020
COOLMAX® Technology Incorporated Into New Menswear Collection At H&M
Apr 24, 2020
Actinium Pharmaceuticals, Inc. Announces Closing of $31.6 Million Public Offering, including Full Exercise of the Underwriters' Option to Purchase Additional Shares
Apr 21, 2020
Actinium Pharmaceuticals, Inc. Announces Pricing of $27.5 Million Public Offering
Apr 20, 2020
The LYCRA Company to Showcase Sustainable Solutions at Kingpins 24 Livestream Event
Mar 05, 2020
CORRECTION - NAV CANADA announces ratification of collective agreement with PIPSC
Feb 05, 2020
Actinium Pharmaceuticals, Inc. to Present at the 22nd Annual BIO CEO & Investor Conference
Jan 17, 2020
The LYCRA Company Marks First Anniversary as New Company
Dec 12, 2019
Star Confirms No Shareholder Meeting Was Held
Dec 09, 2019
Actinium Pharmaceuticals Announces Phase 3 SIERRA Trial Dosimetry Results Support Low Dose Iomab-B for Targeted Lymphodepletion Prior to Adoptive Cell Therapy
Nov 07, 2019
Actinium Pharmaceuticals to Present at the 25th Annual BIO-Europe® 2019 International Partnering Conference
Nov 06, 2019
Actinium Announces Interim Results from Phase 1 Actimab-A CLAG-M Combination Trial in Patients with Relapsed or Refractory AML Accepted for Presentation at ASH 2019
Nov 06, 2019
Actinium Pharmaceuticals to Present New Clinical Findings from SIERRA Trial Supporting the Iomab-ACT Program for Targeted Lymphodepletion for CAR-T and Adoptive Cell Therapies at ASH 2019
Sep 16, 2019
Actinium Pharmaceuticals to Present at the Sachs 19th Annual Biotech in Europe Forum for Global Partnering & Investment
Sep 05, 2019
Actinium Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference
Jul 23, 2019
Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial for Iomab-B
Jul 11, 2019
Actinium Highlights Two Presentations at the Health Physics Society Annual Meeting Supporting the Safety Profile of Iomab-B for SIERRA Trial Caregivers
Jun 26, 2019
Actinium Poster Detailing Actinium-225 Labeled Daratumumab Selected in Top Poster Award Competition at 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting
Jun 20, 2019
Modulus Announces Close Of Beta Test
Jun 20, 2019
Actinium's Portfolio of Antibody Radiation-Conjugates to be Highlighted in Two Oral and Two Poster Presentations at the 2019 Society of Nuclear Medicine and Molecular Imaging Annual Meeting